Lomitapide at Supratherapeutic Plasma Levels Does Not Prolong the QTc Interval—Results from a TQT Study with Moxifloxacin and Ketoconazole

Author： Darpo Borje   Ferber Georg   Zhou Meijian   Sumeray Mark   Sager Philip  

Publisher： Blackwell Publishing

ISSN： 1082-720X

Source： Annals of Noninvasive Electrocardiology, Vol.18, Iss.6, 2013-11, pp. : 577-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Thorough QTc Study Confirms Early Pharmacokinetics/QTc Modeling: A Supratherapeutic Dose of Omarigliptin, a Once‐Weekly DPP‐4 Inhibitor, Does Not Prolong the QTc Interval

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 383-392

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval

By Iannini Paul B  

Expert Opinion on Drug Safety, Vol. 1, Iss. 2, 2002-07 ,pp. : 121-128

Informa Healthcare

Access to resources Recommend Favorite

Metoprolol reduces the QTc interval but does not change QTc dispersion in patients with type 1 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Lomitapide

By  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 5, 2011-10 ,pp. : 347-352

Adis International

Access to resources Recommend Favorite

Effects of Bilastine on T-wave Morphology and the QTc Interval: A Randomized, Double-Blind, Placebo-Controlled, Thorough QTc Study

By Graff Claus  

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 339-351

Adis International

Access to resources Recommend Favorite